R&D | February 07, 2026
£1bn London Cancer Hub expansion wins planning approval
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
This relates to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Subscribe To Our Newsletter & Stay Updated
